These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 39305120)

  • 1. Indole alleviates nonalcoholic fatty liver disease in an ACE2-dependent manner.
    Gao Y; Chen Q; Yang S; Cao J; Li F; Li R; Wu Z; Wang Y; Yuan L
    FASEB J; 2024 Sep; 38(18):e70061. PubMed ID: 39305120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chicoric Acid Ameliorates Nonalcoholic Fatty Liver Disease via the AMPK/Nrf2/NF
    Ding X; Jian T; Li J; Lv H; Tong B; Li J; Meng X; Ren B; Chen J
    Oxid Med Cell Longev; 2020; 2020():9734560. PubMed ID: 33204402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ginsenoside Rg
    Shi Y; Chen J; Qu D; Sun Q; Yu Y; Zhang H; Liu Z; Sha J; Sun Y
    Nutrients; 2024 Mar; 16(6):. PubMed ID: 38542753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indole Alleviates Diet-Induced Hepatic Steatosis and Inflammation in a Manner Involving Myeloid Cell 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 3.
    Ma L; Li H; Hu J; Zheng J; Zhou J; Botchlett R; Matthews D; Zeng T; Chen L; Xiao X; Athrey G; Threadgill DW; Li Q; Glaser S; Francis H; Meng F; Li Q; Alpini G; Wu C
    Hepatology; 2020 Oct; 72(4):1191-1203. PubMed ID: 31953865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.
    Wang P; Wang J; Li D; Ke W; Chen F; Hu X
    J Nutr Biochem; 2020 Jul; 81():108363. PubMed ID: 32388250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatobiliary and pancreatic: Multi-donor fecal microbiota transplantation attenuated high-fat diet-induced hepatic steatosis in mice by remodeling the gut microbiota.
    Shou D; Luo Q; Tang W; Cao C; Huang H; Chen H; Zhou Y
    J Gastroenterol Hepatol; 2023 Dec; 38(12):2195-2205. PubMed ID: 37787118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIRT3 Deficiency Promotes High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Correlation with Impaired Intestinal Permeability through Gut Microbial Dysbiosis.
    Chen M; Hui S; Lang H; Zhou M; Zhang Y; Kang C; Zeng X; Zhang Q; Yi L; Mi M
    Mol Nutr Food Res; 2019 Feb; 63(4):e1800612. PubMed ID: 30525304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-(1-7), the product of ACE2 ameliorates NAFLD by acting through its receptor Mas to regulate hepatic mitochondrial function and glycolipid metabolism.
    Song LN; Liu JY; Shi TT; Zhang YC; Xin Z; Cao X; Yang JK
    FASEB J; 2020 Dec; 34(12):16291-16306. PubMed ID: 33078906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smilax China L. polysaccharide prevents HFD induced-NAFLD by regulating hepatic fat metabolism and gut microbiota.
    Zhang W; Yu L; Yang Q; Zhang J; Wang W; Hu X; Li J; Zheng G
    Phytomedicine; 2024 May; 127():155478. PubMed ID: 38452696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnane X receptor exacerbates nonalcoholic fatty liver disease accompanied by obesity- and inflammation-prone gut microbiome signature.
    Kim S; Choi S; Dutta M; Asubonteng JO; Polunas M; Goedken M; Gonzalez FJ; Cui JY; Gyamfi MA
    Biochem Pharmacol; 2021 Nov; 193():114698. PubMed ID: 34303710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.
    Matsui M; Fukunishi S; Nakano T; Ueno T; Higuchi K; Asai A
    mBio; 2021 Aug; 12(4):e0115521. PubMed ID: 34225483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease.
    Wang W; Zhao J; Gui W; Sun D; Dai H; Xiao L; Chu H; Du F; Zhu Q; Schnabl B; Huang K; Yang L; Hou X
    Br J Pharmacol; 2018 Feb; 175(3):469-484. PubMed ID: 29139555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatoprotective Effects of Indole, a Gut Microbial Metabolite, in Leptin-Deficient Obese Mice.
    Knudsen C; Neyrinck AM; Leyrolle Q; Baldin P; Leclercq S; Rodriguez J; Beaumont M; Cani PD; Bindels LB; Lanthier N; Delzenne NM
    J Nutr; 2021 Jun; 151(6):1507-1516. PubMed ID: 33693866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteroides ovatus alleviates high-fat and high-cholesterol -induced nonalcoholic fatty liver disease via gut-liver axis.
    Sun C; Xiong X; Liu M; Liang Q; Zhao Q; Wei G; Shi J; Li X
    Biomed Pharmacother; 2024 Sep; 178():117156. PubMed ID: 39032286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A botanical dietary supplement from white peony and licorice attenuates nonalcoholic fatty liver disease by modulating gut microbiota and reducing inflammation.
    Chen L; Kan J; Zheng N; Li B; Hong Y; Yan J; Tao X; Wu G; Ma J; Zhu W; Sheng L; Chen L; Li B; Zhong J; Du J; Li H
    Phytomedicine; 2021 Oct; 91():153693. PubMed ID: 34403877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis.
    Vitaglione P; Mazzone G; Lembo V; D'Argenio G; Rossi A; Guido M; Savoia M; Salomone F; Mennella I; De Filippis F; Ercolini D; Caporaso N; Morisco F
    J Nutr Sci; 2019; 8():e15. PubMed ID: 31037218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the fecal microbiome and metabolome by resistant dextrin ameliorates hepatic steatosis and mitochondrial abnormalities in mice.
    Zhang Z; Chen X; Cui B
    Food Funct; 2021 May; 12(10):4504-4518. PubMed ID: 33885128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supplementation of Silymarin Alone or in Combination with Salvianolic Acids B and Puerarin Regulates Gut Microbiota and Its Metabolism to Improve High-Fat Diet-Induced NAFLD in Mice.
    Wang X; Jin Y; Di C; Zeng Y; Zhou Y; Chen Y; Pan Z; Li Z; Ling W
    Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in mice.
    Ding Y; Yanagi K; Yang F; Callaway E; Cheng C; Hensel ME; Menon R; Alaniz RC; Lee K; Jayaraman A
    Elife; 2024 Feb; 12():. PubMed ID: 38412016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.